Biofidelity Prepares to Launch Lung Cancer Mutation Detection Assay
360Dx,
NEW YORK – UK cancer molecular diagnostics company Biofidelity plans to launch its pyrophosphorolysis-based lung cancer…
NEW YORK – UK cancer molecular diagnostics company Biofidelity plans to launch its pyrophosphorolysis-based lung cancer…
NEW YORK – UK cancer molecular diagnostics company Biofidelity plans to launch its pyrophosphorolysis-based lung cancer…